100 related articles for article (PubMed ID: 3590075)
1. An international collaborative study on the performance of protein C antigen assays. Report of the ICTH subcommittee on protein C. International Committee on Thrombosis and Haemostasis.
Bertina RM
Thromb Haemost; 1987 Feb; 57(1):112-7. PubMed ID: 3590075
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter study on purified protein C concentrates and defined plasma levels].
Regnault V; Houbouyan L; Michalski C; Vergnes C; Briquel ME; Droulle C; Delattre H; Boisseau M; Alexandre P; Poltron G
Ann Biol Clin (Paris); 1991; 49(6):345-50. PubMed ID: 1759729
[TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of three commercial methods for measuring protein S antigen.
Tripodi A; Bertina RM; Conard J; Pabinger I; Sala N; Mannucci PM
Thromb Haemost; 1992 Aug; 68(2):149-54. PubMed ID: 1412159
[TBL] [Abstract][Full Text] [Related]
4. Standardization of protein C in plasma: establishment of an international standard.
Hubbard AR
Thromb Haemost; 1988 Jun; 59(3):464-7. PubMed ID: 3187933
[TBL] [Abstract][Full Text] [Related]
5. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
[TBL] [Abstract][Full Text] [Related]
6. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
[TBL] [Abstract][Full Text] [Related]
7. Multicenter comparison of five functional and two immunological assays for protein C.
Mannucci PM; Boyer C; Tripodi A; Viganò-D'Angelo S; Wolf M; Valsecchi C; D'Angelo A; Meyer D; Larrieu MJ
Thromb Haemost; 1987 Feb; 57(1):44-8. PubMed ID: 3590079
[TBL] [Abstract][Full Text] [Related]
8. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of human activated protein C. 1st communication: plasma concentration and excretion of a lyophilized purified human activated protein C after intravenous administration in the mouse and the rabbit.
Ishii S; Mochizuki T; Nagao T; Sugiki S; Kudo S; Harakawa N; Taniguchi K; Igarashi Y; Kondo S; Kiyoki M
Arzneimittelforschung; 1995 May; 45(5):636-44. PubMed ID: 7612068
[TBL] [Abstract][Full Text] [Related]
11. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new venom-based clotting assay of protein C.
Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
14. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
[TBL] [Abstract][Full Text] [Related]
15. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S.
Marlar RA; Montgomery RR; Broekmans AW
Thromb Haemost; 1989 Jun; 61(3):529-31. PubMed ID: 2529664
[No Abstract] [Full Text] [Related]
16. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
[TBL] [Abstract][Full Text] [Related]
17. Successful protein C concentrate administration during initiation of oral anticoagulation in adult patients with severe congenital protein C deficiency: report of two cases.
Imberti D; Pierfranceschi MG
Pathophysiol Haemost Thromb; 2008; 36(2):53-7. PubMed ID: 19127082
[TBL] [Abstract][Full Text] [Related]
18. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.
van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN
Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163
[TBL] [Abstract][Full Text] [Related]
19. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo.
Orthner CL; Kolen B; Drohan WN
Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays.
Pabinger I; Kyrle PA; Speiser W; Stoffels U; Jung M; Lechner K
Thromb Haemost; 1990 Jun; 63(3):407-12. PubMed ID: 2402742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
